Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications. - Green JL; Dailey-Govoni T; Vosburg SK (Pain and therapy, 2026)